BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALTUV • FR0013345493

1.316 EUR
-0.01 (-1.05%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall ALTUV gets a fundamental rating of 4 out of 10. We evaluated ALTUV against 112 industry peers in the Machinery industry. ALTUV has only an average score on both its financial health and profitability. ALTUV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ALTUV had positive earnings in the past year.
  • ALTUV had a positive operating cash flow in the past year.
  • ALTUV had positive earnings in each of the past 5 years.
  • Of the past 5 years ALTUV 4 years had a positive operating cash flow.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • ALTUV has a Return On Assets of 1.36%. This is in the lower half of the industry: ALTUV underperforms 66.07% of its industry peers.
  • With a Return On Equity value of 2.41%, ALTUV is not doing good in the industry: 69.64% of the companies in the same industry are doing better.
  • With a Return On Invested Capital value of 2.84%, ALTUV is not doing good in the industry: 70.54% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALTUV is below the industry average of 8.65%.
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROIC 2.84%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • ALTUV has a Profit Margin (2.64%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of ALTUV has declined.
  • The Operating Margin of ALTUV (5.93%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of ALTUV has grown nicely.
  • Looking at the Gross Margin, with a value of 38.14%, ALTUV is in line with its industry, outperforming 45.54% of the companies in the same industry.
  • ALTUV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • ALTUV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ALTUV has less shares outstanding than it did 1 year ago.
  • ALTUV has more shares outstanding than it did 5 years ago.
  • ALTUV has a better debt/assets ratio than last year.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • ALTUV has an Altman-Z score of 1.38. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ALTUV (1.38) is worse than 66.07% of its industry peers.
  • The Debt to FCF ratio of ALTUV is 7.69, which is on the high side as it means it would take ALTUV, 7.69 years of fcf income to pay off all of its debts.
  • ALTUV has a Debt to FCF ratio (7.69) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.39 indicates that ALTUV is not too dependend on debt financing.
  • ALTUV has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: ALTUV outperforms 47.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Altman-Z 1.38
ROIC/WACC0.38
WACC7.39%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.05 indicates that ALTUV has no problem at all paying its short term obligations.
  • ALTUV has a better Current ratio (2.05) than 78.57% of its industry peers.
  • A Quick Ratio of 1.31 indicates that ALTUV should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.31, ALTUV is in the better half of the industry, outperforming 72.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.31
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ALTUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 190.18%, which is quite impressive.
  • Measured over the past years, ALTUV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -64.42% on average per year.
  • The Revenue has decreased by -7.99% in the past year.
  • Measured over the past years, ALTUV shows a quite strong growth in Revenue. The Revenue has been growing by 14.65% on average per year.
EPS 1Y (TTM)190.18%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%

3.2 Future

  • Based on estimates for the next years, ALTUV will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.51% on average per year.
  • The Revenue is expected to grow by 3.57% on average over the next years.
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.80, the valuation of ALTUV can be described as rather expensive.
  • Based on the Price/Earnings ratio, ALTUV is valued a bit cheaper than the industry average as 69.64% of the companies are valued more expensively.
  • ALTUV is valuated rather cheaply when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 12.78, which indicates a correct valuation of ALTUV.
  • 65.18% of the companies in the same industry are more expensive than ALTUV, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of ALTUV to the average of the S&P500 Index (27.86), we can say ALTUV is valued rather cheaply.
Industry RankSector Rank
PE 18.8
Fwd PE 12.78
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ALTUV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALTUV is cheaper than 65.18% of the companies in the same industry.
  • ALTUV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALTUV is cheaper than 87.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.78
EV/EBITDA 8.29
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALTUV's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3Y14.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.50%, ALTUV has a reasonable but not impressive dividend return.
  • ALTUV's Dividend Yield is rather good when compared to the industry average which is at 1.45. ALTUV pays more dividend than 82.14% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, ALTUV pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

More info and screens

Find the best dividend stocksShow peers with best dividend

BIO-UV GROUP SAS

EPA:ALTUV (2/6/2026, 7:00:00 PM)

1.316

-0.01 (-1.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-22
Earnings (Next)N/A
Inst Owners5.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.62M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target3.06 (132.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.8
Fwd PE 12.78
P/S 0.49
P/FCF 6.78
P/OCF 3.91
P/B 0.45
P/tB 3.63
EV/EBITDA 8.29
EPS(TTM)0.07
EY5.32%
EPS(NY)0.1
Fwd EY7.83%
FCF(TTM)0.19
FCFY14.75%
OCF(TTM)0.34
OCFY25.6%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROCE 3.87%
ROIC 2.84%
ROICexc 2.84%
ROICexgc 7.55%
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
FCFM 7.26%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Debt/EBITDA 3.38
Cap/Depr 79.6%
Cap/Sales 5.35%
Interest Coverage 250
Cash Conversion 99.7%
Profit Quality 275.52%
Current Ratio 2.05
Quick Ratio 1.31
Altman-Z 1.38
F-Score7
WACC7.39%
ROIC/WACC0.38
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)190.18%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.21%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A

BIO-UV GROUP SAS / ALTUV.PA FAQ

Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?

ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.


What is the valuation status of BIO-UV GROUP SAS (ALTUV.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for BIO-UV GROUP SAS?

BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.


What is the valuation of BIO-UV GROUP SAS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BIO-UV GROUP SAS (ALTUV.PA) is 18.8 and the Price/Book (PB) ratio is 0.45.


What is the financial health of BIO-UV GROUP SAS (ALTUV.PA) stock?

The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.